VCYT
VERACYTE, INC.
Nasdaq Services-Medical Laboratories Large accelerated filer

Key Financials

Revenue
$517.1M
↑ 16.0%
Net Income
$66.4M
↑ 174.9%
Gross Profit
$362.5M
↑ 21.6%
Operating Income
$57.8M
↑ 257.9%
EPS (Diluted)
$0.82
↑ 164.5%
Shareholders' Equity
$1.3B
↑ 11.4%
Cash & Equivalents
$362.6M
↑ 51.7%
Total Assets
$1.4B
↑ 8.2%

Recent SEC Filings

Form Type Filed Date Link
10-Q 7/31/2026 View on SEC
8-K 7/30/2026 View on SEC
4 6/22/2026 View on SEC
144 6/18/2026 View on SEC
4 6/15/2026 View on SEC
4 6/15/2026 View on SEC
4 6/15/2026 View on SEC
4 6/15/2026 View on SEC
4 6/15/2026 View on SEC
4 6/15/2026 View on SEC

Company Information

Field Value
Ticker VCYT
Company Name VERACYTE, INC.
CIK 1384101
Sector Services-Medical Laboratories
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 8071
SIC Description Services-Medical Laboratories
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (650) 243-6300